{"id":564520,"date":"2021-09-20T17:00:02","date_gmt":"2021-09-20T17:00:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=564520"},"modified":"2021-09-20T17:00:02","modified_gmt":"2021-09-20T17:00:02","slug":"neuralgia-treatment-market-expansion-to-be-persistent-through-20212031-rising-geriatric-population-to-propel-market-demand","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/neuralgia-treatment-market-expansion-to-be-persistent-through-20212031-rising-geriatric-population-to-propel-market-demand_564520.html","title":{"rendered":"Neuralgia Treatment Market Expansion to be Persistent through 2021-2031; Rising Geriatric Population to Propel Market Demand"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1632130778.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Neuralgia Treatment Market Expansion to be Persistent through 2021-2031; Rising Geriatric Population to Propel Market Demand\" src=\"https:\/\/www.abnewswire.com\/uploads\/1632130778.png\" alt=\"Neuralgia Treatment Market Expansion to be Persistent through 2021-2031; Rising Geriatric Population to Propel Market Demand\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Neuralgia Treatment Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">In the Neuralgia Treatment market, pharmacologic agents will remain as the primary line of treatment for many. The most common neuralgias that drive the Neuralgia Treatment market include trigeminal, postherpetic, glossopharyngeal, and occipital neuralgia. These neuralgias differ in their pathophysiology, topography, complications, and treatment approach, necessitating awareness amongst individuals.<\/div>\n<p style=\"text-align: justify;\">The global Neuralgia Treatment market is primarily driven by the increase in the geriatric population around the world. The disorder is more common in people aged 50 years or more, which drives the Neuralgia Treatment market. Although, it can occur at any age. Adults suffering from multiple sclerosis and diabetes also have a high risk of developing neuralgias, which also significantly contributes to the Neuralgia Treatment market.<\/p>\n<p style=\"text-align: justify;\">The Market Research Survey by &ldquo;Fact.MR, A Market Research and Competitive Intelligence Provider&rdquo; highlights the key reasons behind increasing demand of Neuralgia Treatment. Neuralgia Treatment market drivers and constraints, threats and opportunities, regional segmentation and opportunity assessment, end-use\/application prospects review are addressed in the&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.factmr.com\/report\/2282\/neuralgia-treatment-market\">Neuralgia Treatment market survey report<\/a>. The survey report provides a comprehensive analysis of Neuralgia Treatment market key trends and insights on Neuralgia Treatment market size and share.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>To Get In-depth Insights Request for Brochure here &ndash;&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.factmr.com\/connectus\/sample?flag=B&amp;rep_id=2282\">https:\/\/www.factmr.com\/connectus\/sample?flag=B&amp;rep_id=2282<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Neuralgias Market: Segmentation<\/strong><\/p>\n<p style=\"text-align: justify;\">Tentatively, the global Neuralgia Treatment market can be segmented on the basis of treatment type, distribution channel, and geography.<\/p>\n<p style=\"text-align: justify;\"><strong>Based on treatment type, the global Neuralgia Treatment market is segmented as:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Medications for Neuralgia Treatment<\/li>\n<ul>\n<li>Anticonvulsant Medicines<\/li>\n<ul>\n<li>Carbamazepine<\/li>\n<li>Oxcarbazepine<\/li>\n<li>Topiramate<\/li>\n<li>Gabapentin<\/li>\n<li>Pregabalin<\/li>\n<li>Clonazepam<\/li>\n<li>Phenytoin<\/li>\n<li>Lamotrigine<\/li>\n<li>Valproic acid<\/li>\n<\/ul>\n<li>Tricyclic Antidepressants<\/li>\n<ul>\n<li>Amitriptyline<\/li>\n<li>Nortriptyline<\/li>\n<\/ul>\n<\/ul>\n<li>Surgeries for Neuralgia Treatment<\/li>\n<ul>\n<li>Balloon Compression<\/li>\n<li>Glycerol Injection<\/li>\n<li>Radiofrequency Thermal Lesioning<\/li>\n<li>Stereotactic Radiosurgery<\/li>\n<li>Microvascular Decompression<\/li>\n<\/ul>\n<li>Complementary Approaches for Neuralgia Treatment (in combination with medications)<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Based on distribution channel, the global Neuralgia Treatment market is segmented as:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Hospital Pharmacies<\/li>\n<li>Retail Pharmacies<\/li>\n<li>Drug Stores<\/li>\n<li>Online Pharmacies<\/li>\n<li>Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Key questions answered in&nbsp;Neuralgia Treatment&nbsp;Market Survey Report:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>What is the current scenario and key trends in&nbsp;Neuralgia Treatment&nbsp;Market?<\/li>\n<li>What are the key strategies companies are adopting to increase their consumer base?<\/li>\n<li>What are the key categories within the&nbsp;Neuralgia Treatment&nbsp;segments and their future potential?<\/li>\n<li>What are the major&nbsp;Neuralgia Treatment&nbsp;Market drivers and their expected impact during the short, medium, and long terms?<\/li>\n<li>What is the&nbsp;Neuralgia Treatment&nbsp;Market size and what are the opportunities for the key players?<\/li>\n<\/ol>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request Customized Report as Per Your Requirements &ndash;&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.factmr.com\/connectus\/sample?flag=RC&amp;rep_id=2282\">https:\/\/www.factmr.com\/connectus\/sample?flag=RC&amp;rep_id=2282<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Neuralgia Treatment Market: Key Players<\/strong><\/p>\n<p style=\"text-align: justify;\">Some of the key players operating in the global neuralgias market are Allergan Plc, Merz Pharma GmbH &amp; Co., Biogen, Inc., Merz Pharma GmbH &amp; Co., Abbott Laboratories, Trigemina Inc., Pfizer Inc., Novartis, GlaxoSmithKline Plc. F, Lupin, and others.<\/p>\n<p style=\"text-align: justify;\">The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Essential Takeaways from the this Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Comparison of prominent players operating in the market.<\/li>\n<li>Recent developments and key strategies adopted by key players.<\/li>\n<li>Study of the micro and macro-economic growth indicators.<\/li>\n<li>Impact of the various factors on the value chain.<\/li>\n<li>Evaluation of current&nbsp;Neuralgia Treatment&nbsp;market size, forecast and technological advancements within the industry.<\/li>\n<li>Current Insights influencing the scenario and key trends in&nbsp;Neuralgia Treatment&nbsp;market.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Enquire Before Buying Here &#8211;&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.factmr.com\/connectus\/sample?flag=EB&amp;rep_id=2282\">https:\/\/www.factmr.com\/connectus\/sample?flag=EB&amp;rep_id=2282<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>The Report Covers Exhaustive Analysis On:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Neuralgia Treatment&nbsp;Market Drivers, Segments and Restraints.<\/li>\n<li>Neuralgia Treatment&nbsp;Market Survey and Dynamics<\/li>\n<li>Neuralgia Treatment&nbsp;Market Size &amp; Demand<\/li>\n<li>Neuralgia Treatment&nbsp;Key Trends\/Issues\/Challenges<\/li>\n<li>Neuralgia Treatment&nbsp;Sales, Competition &amp; Companies involved<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Explore Fact.MR&rsquo;s Coverage on the&nbsp;Healthcare&nbsp;Domain:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.factmr.com\/report\/digital-therapeutics-market\">Digital Therapeutics Market<\/a>&nbsp;&#8211;&nbsp;<\/strong>According to the latest research by Fact.MR, the digital therapeutics market is set to witness exponential growth during 2021-2031. Increasing adoption for digital health to deliver evidence-based therapeutics will witness a promising growth outlook for digital therapeutics in the long run.<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.factmr.com\/report\/radiation-shielding-market\">Radiation Shielding Market<\/a><\/strong>&nbsp;&#8211; According to the latest research by Fact MR, the radiation shielding market is set to witness steady growth during 2021-2031. Demand for the market will witness a steady recovery in the short term, with an optimistic growth outlook in the long run.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About Fact.MR<\/strong><\/p>\n<p style=\"text-align: justify;\">Market research and consulting agency with a difference! That&rsquo;s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range &ndash; from automotive &amp; industry 4.0 to healthcare &amp; retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we&rsquo;ll be an able research partner<strong>.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Contact:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br \/> <\/strong>US Sales Office:<br \/> 11140 Rockville Pike&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br \/> Suite 400<br \/> Rockville, MD 20852<br \/> United States<br \/> Tel: +1 (628) 251-1583<br \/> E-Mail:&nbsp;<a rel=\"nofollow\" href=\"mailto:sales@factmr.com\">sales@factmr.com<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Corporate Headquarter:<br \/> <\/strong>Unit No: AU-01-H Gold Tower (AU),<br \/> Plot No: JLT-PH1-I3A,<br \/> Jumeirah Lakes Towers,<br \/> Dubai, United Arab Emirates<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/factmr.com_74933.html\" rel=\"nofollow\">Fact.MR<\/a><br \/><strong>Contact Person:<\/strong> Anup Kumar<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=neuralgia-treatment-market-expansion-to-be-persistent-through-20212031-rising-geriatric-population-to-propel-market-demand\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 6282511583<br \/><strong>Address:<\/strong>US Sales Office:  11140 Rockville Pike<br \/><strong>City:<\/strong> Rockville<br \/><strong>State:<\/strong> Maryland<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.factmr.com\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.factmr.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.factmr.com\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=neuralgia-treatment-market-expansion-to-be-persistent-through-20212031-rising-geriatric-population-to-propel-market-demand\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neuralgia Treatment Market In the Neuralgia Treatment market, pharmacologic agents will remain as the primary line of treatment for many. The most common neuralgias that drive the Neuralgia Treatment market include trigeminal, postherpetic, glossopharyngeal, and occipital neuralgia. These neuralgias differ &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/neuralgia-treatment-market-expansion-to-be-persistent-through-20212031-rising-geriatric-population-to-propel-market-demand_564520.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405],"tags":[],"class_list":["post-564520","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/564520","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=564520"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/564520\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=564520"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=564520"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=564520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}